• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Merck CEO Frazier leaves Trump council

August 14, 2017 By Sarah Faulkner

MerckMerck (NYSE:MRK) announced today that chief executive Kenneth Frazier plans to resign from President Donald Trump’s American Manufacturing Council, citing the president’s mild-mannered response to a white nationalist rally in Virginia on Saturday.

The “Unite The Right” gathering turned deadly when a car mowed down a group of counter-protesters, killing at least one person and injuring others. Trump responded to the violence by saying that “many sides” were responsible. The remark drew immediate criticism from both sides of the aisle, with many demanding that Trump specifically denounce white supremacists.

“America’s leaders must honor our fundamental views by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all people are created equal,” Merck tweeted this morning.

“Our country’s strength stems from its diversity and the contributions made by men and women of different faiths, races, sexual orientations and political beliefs.”

The president responded to Frazier’s resignation on Twitter this morning, writing “Now that Ken Frazier of Merck Pharma has resigned from President’s Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES!”

As Trump faced growing outrage over his response to the events in Charlottesville, vice president Mike Pence condemned the violence perpetrated by white supremacists.

“We have no tolerance for hate and violence from white supremacists, neo-Nazis or the KKK,” Pence reportedly said during a trip to Colombia. “These dangerous fringe groups have no place in American public life and in the American debate and we condemn them in the strongest possible terms.”

The driver of the car that killed 32-year old Heather Heyer on Saturday is being held on suspicion of second-degree murder, malicious wounding and failure to stop in an accident that resulted in death, according to CNN.

Today, U.S. attorney general Jeff Sessions labeled the attack as an act of “domestic terrorism.”

“You can be sure we will charge and advance the investigation toward the most serious charges that can be brought because this is unequivocally an unacceptable evil attack,” Sessions said, according to The New York Times.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2.

Filed Under: Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Capitol Hill, Merck

IN CASE YOU MISSED IT

  • Enable Injections, Sanofi obtain approval for on-body myeloma therapy in Japan
  • Abbott sets Libre Duo glucose-ketone sensor US launch for December
  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • MiniMed completes split from Medtronic
  • Insulet’s Omnipod Discover data platform begins full US rollout

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS